Table 3.
Source/ condition | Design | Population/ denominator | Timescale | Case ascertainment method | Diagnostic method | Outcome | Potential bias/methodological limitations |
---|---|---|---|---|---|---|---|
Morrison et al. (1995) [6] HD | Population-based study of prevalence | Northern Ireland population of 1,569,971 based on 1991 national census | Prevalence estimated on April 21, 1991 | Northern Ireland GP records; neurologist, psychiatrist and geriatrician records; Department of Medical Genetics diagnostic records | DNA-confirmed diagnoses for all patients | Prevalence of 6.4/100,000 | Small founder effect due to large families; however, families not large enough to cause bias in population statistics |
James et al. (1994) [7] HD | Population-based study of prevalence | South and Mid Glamorgan, and Gwent; population of 1,393,900 based on 1991 national census | Prevalence estimated on March 1, 1994 | HD register for South Wales | Details of formal diagnosis in register; notes of symptom type and onset provided | Prevalence of 6.2/100,000 | All known living cases of HD studied; potential for cases not included in register, and subsequent underestimation of prevalence |
Watt and Seller (1993) [8] HD | Population-based study of prevalence | Oxford Region Health Authority under NHS; population of 2,520,000 | Prevalence estimated on live patients on January 1, 1988 | Oxford region medical genetics department records; it is thought by the time of the study all persons affected in 1988 would have been referred and ascertained | Confirmed by presymptomatic linkage test | Prevalence of 4.0/100,000 | None identified |
HD = Huntington's disease; NHS = National Health Service; GP = general practitioner.